PACS Group (NYSE:PACS) Stock: Insider Jason Hulse Murray Sells 1,620 Shares

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 1,620 shares of PACS Group stock in a transaction dated Monday, October 19th. The shares were sold at an average price of $47.57, for a total value of $77,063.40. Following the completion of the sale, the chief executive officer directly owned 54,314,900 shares in the company, valued at approximately $2,583,759,793. This represents a 0.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The shares were sold at an average price of $47.62, for a total value of $314,768.20.
• On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The shares were sold at an average price of $47.65, for a total value of $1,785,779.05.
• On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The shares were sold at an average price of $47.61, for a total value of $402,875.82.
• On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The shares were sold at an average price of $47.27, for a total value of $5,201,354.45.
• On Wednesday, October 14th, Jason Murray sold 232 shares of PACS Group stock. The stock was sold at an average price of $45.00, for a total value of $10,440.00.
• On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The stock was sold at an average price of $42.48, for a total value of $30,458.16.
• On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The stock was sold at an average price of $43.09, for a total value of $1,550,162.75.
• On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The shares were sold at an average price of $42.66, for a total value of $1,033,395.84.
• On Friday, October 2nd, Jason Murray sold 26,052 shares of PACS Group stock. The shares were sold at an average price of $42.51, for a total value of $1,107,470.52.
• On Thursday, October 1st, Jason Murray sold 33,032 shares of PACS Group stock. The shares were sold at an average price of $41.13, for a total value of $1,358,606.16.

PACS Group Price Performance

NYSE:PACS opened at $47.62 on Friday. PACS Group, Inc. has a 1-year low of $10.31 and a 1-year high of $49.49. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21. The firm has a fifty day simple moving average of $43.66 and a 200 day simple moving average of $40.91. The stock has a market capitalization of $7.54 billion, a PE ratio of 27.69, a P/E/G ratio of 1.46 and a beta of -0.08.

PACS Group (NYSE:PACS) last issued its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.09. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. On average, research analysts expect that PACS Group, Inc. will post 2.13 EPS for the current fiscal year.

More PACS Group News

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: Analysts remain generally optimistic: PACS Group has a consensus “Moderate Buy” rating and an average price target of $58.80, above its recent trading level. RBC, UBS, and Truist have cited targets ranging from $57 to $62. The company also recently exceeded quarterly EPS and revenue expectations. Insider Selling: PACS Group CEO Sells Stock
• Neutral Sentiment: CEO Jason Murray sold 45,707 PACS shares for approximately $2.18 million over October 19–21 under a pre-arranged Rule 10b5-1 trading plan. The sales included 37,477 shares at $47.65, 6,610 at $47.62, and 1,620 at $47.57. PACS Group CEO Sells 45,707 Shares
• Negative Sentiment: Repeated CEO selling may weigh on investor sentiment, particularly after additional sales earlier in October. However, the transactions represent only a very small reduction in ownership; Murray still directly owns roughly 54.27 million shares. Because the trades were executed under a 10b5-1 plan, they were likely scheduled in advance rather than reflecting a newly disclosed view that PACS Group is overvalued. PACS Group Insider Sale

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Sterling Capital Management LLC raised its stake in PACS Group by 19.3% in the 3rd quarter. Sterling Capital Management LLC now owns 8,569 shares of the company’s stock valued at $356,000 after acquiring an additional 1,387 shares during the period. Inspire Investing LLC lifted its holdings in PACS Group by 11.0% during the 3rd quarter. Inspire Investing LLC now owns 67,630 shares of the company’s stock valued at $2,810,000 after purchasing an additional 6,718 shares during the last quarter. Cantor Fitzgerald Investment Advisors L.P. acquired a new stake in PACS Group during the 3rd quarter valued at $1,920,000. Nisa Investment Advisors LLC boosted its position in PACS Group by 11.0% during the third quarter. Nisa Investment Advisors LLC now owns 2,327 shares of the company’s stock worth $97,000 after purchasing an additional 230 shares during the period. Finally, USA Financial Formulas bought a new position in PACS Group during the third quarter worth $46,000.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on PACS shares. Truist Financial set a $62.00 price objective on shares of PACS Group in a research note on Wednesday, September 2nd. JPMorgan Chase & Co. upped their target price on shares of PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a report on Friday, September 4th. Weiss Ratings upgraded shares of PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. Oppenheimer lifted their price target on PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Finally, Zacks Research cut PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Five analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $58.80.

About PACS Group

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.